Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001381358 | SCV001579721 | pathogenic | not provided | 2023-11-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg52*) in the CABP4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CABP4 are known to be pathogenic (PMID: 25307992). This variant is present in population databases (rs745382789, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with congenital stationary night blindness (PMID: 25307992). ClinVar contains an entry for this variant (Variation ID: 1069487). For these reasons, this variant has been classified as Pathogenic. |
Genomics England Pilot Project, |
RCV001542588 | SCV001760278 | pathogenic | Cone-rod synaptic disorder, congenital nonprogressive | no assertion criteria provided | clinical testing |